Summary & Overview
HCPCS C9470: Aripiprazole Lauroxil Injection, 1 mg
HCPCS Level II code C9470 designates an injection of aripiprazole lauroxil at a 1 mg unit. The code captures administration of a long-acting injectable antipsychotic formulation used in psychiatric care and is relevant for tracking utilization, billing accuracy, and payer coverage for injectable psychiatric medications nationwide. Nationally, clear coding for long-acting injectable antipsychotics supports care continuity for patients with schizophrenia spectrum and other psychotic disorders who receive parenteral antipsychotic therapy.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find benchmarks for coverage and reimbursement approaches, common clinical and service-line contexts for use, and policy updates that affect billing and payment for injectable psychiatric medications. The summary outlines typical sites of service and explains what data is available for associated claims elements. Where input data is missing, the text notes that information is not available in the input rather than providing fabricated details.
This publication is aimed at billing managers, revenue cycle leaders, and clinicians involved in administering and billing for long-acting injectable antipsychotics, offering concise reference material on coding, service context, and payer coverage considerations at a national level.
Billing Code Overview
HCPCS Level II code C9470 represents an injection of aripiprazole lauroxil, 1 mg. This billing code denotes a pharmacologic administration service for a long-acting injectable antipsychotic formulation of aripiprazole lauroxil.
Service type: Medication administration (injectable antipsychotic)
Typical site of service: Outpatient clinic, behavioral health clinic, or physician office where injectable psychiatric medications are administered.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical adult patient with schizophrenia or schizoaffective disorder presents for scheduled long-acting injectable antipsychotic therapy. The patient arrives at an outpatient behavioral health clinic or specialty psychiatry clinic that administers intramuscular injections. After verification of identity, current medications, allergies, and a brief assessment of mental state and injection site, a registered nurse or trained medical assistant prepares the dose of aripiprazole lauroxil in accordance with manufacturer guidance. The clinician documents indication, consent, medication lot number, and injection site (typically gluteal or deltoid). The patient is observed in the clinic for a short period for adverse reactions and discharge instructions are provided for expected side effects and next scheduled dose.
Common sites of service include outpatient behavioral health clinics, psychiatric specialty clinics, community mental health centers, and hospital outpatient departments. The typical workflow includes medication reconciliation, injection preparation and administration, post-injection observation, and documentation in the electronic medical record.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, Separately Identifiable Evaluation and Management Service by the Same Physician on the Same Day of the Procedure or Other Service | Use when a significant E/M visit is performed on the same day as the injection and is unrelated to the injection itself. |